Unity Biotechnology Inc (STU:9U90)
€ 1.376 -0.03 (-2.13%) Market Cap: 23.80 Mil Enterprise Value: 8.78 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 31/100

UNITY Biotechnology Inc at UBS Global Healthcare Conference Transcript

May 25, 2022 / 03:30PM GMT
Release Date Price: €6.93 (-0.66%)
Unidentified Analyst

Good afternoon, everyone. Welcome to the UBS Global Healthcare Conference. Thank you very much for joining us in person today. Very happy to have Unity Biotechnology here with us presenting and we'll open up for a fireside chat as well.

Joining us from Unity is Anirvan Ghosh, CEO. And with that, I'll turn it to you.

Anirvan Ghosh
Unity Biotechnology, Inc. - CEO & Director

Thanks, Aliana. Thanks for having me here. So I thought I would just kind of provide a very brief overview of where we are and our near-term data readouts. It's a very exciting year for us as when we chatted last week, I mentioned that we were -- a number of important readouts between now and Q1 of next year. And I just want to kind of tee those up, and then we can talk about the background, science, the details of what we learned in the Phase I study and what's coming up, yes?

So this slide just provides you an overview of our therapeutic approach and the diseases we're targeting and the near-term milestones. The company is focused on developing a new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot